Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration
{{output}}
Immunotherapy has revolutionized cancer treatment, yet its efficacy in hepatocellular carcinoma (HCC) remains limited and the mechanisms of resistance are poorly defined. Using in vivo CRISPR-Cas9 screens, we identify serine/threonine kinase 40 (STK40) as a pr... ...
